Skip to content

MEDIFAR

Active Private limited companyfounded 1985active for 41 yearsNoordkaai 9, 8870 IzegemKBO/BCE: BE 0428.055.258 subsidiary of
Part of the group 42 companies

Timeline

53 events since 1985

The 2026 accounts are due by 31-07-2027.

2026
1 director appointed, 1 resignation, 1 reappointment resigns · , and act as permanent representatives · appointed6 points ▸
  • Director resignation,
  • Permanent representative,
  • Director appointment,
  • Permanent representative,
  • Director reappointment, (managing director)
  • Permanent representative,
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Annual accounts 2025 filed PDFabbreviated format · 80 days before the deadline
2025
Annual accounts 2024 filed PDFabbreviated format · 45 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0428055258
2024
Annual accounts 2023 filed PDFabbreviated format · 50 days before the deadline
2023
Annual accounts 2022 filed PDFabbreviated format · 52 days before the deadline
2022
New chair of the board appointed, resigned · , and act as permanent representatives · Board meeting of 01-09-20228 points ▸
  • General meeting, 30-08-2022
  • Director appointment,
  • Permanent representative,
  • Director resignation,
  • Permanent representative,
  • Board meeting, 01-09-2022
  • Director appointment, (chair of the board)
  • Permanent representative,

Open the deed in the Belgian Official Gazette

Annual accounts 2021 filed PDFabbreviated format · 54 days before the deadline
2021
Highest result from 2006 to 2025 net €69,566 ▲57,660% The operating result of €90,910 and the net result of €69,566 are both a record.
Equity above €500,000 equity €552,678 ▲14.4% After 11 profitable years in a row, equity reaches €552,678.
Annual accounts 2020 filed PDFabbreviated format · 47 days before the deadline
1 director appointed, 1 manager resigning changes role from manager to director · resigns as manager · appointed as director · General meeting of 22-12-20209 points ▸
  • General meeting, 22-12-2020
  • 7,500 shares
  • Director resignation, (manager)
  • Director resignation, (manager)
  • Director appointment, (director (not named in the articles))
  • Director appointment, (director (not named in the articles))
  • Permanent representative,
  • Permanent representative,
  • Registered office clause, Noordkaai 9, 8870 Izegem
  • The deed holds 7 more points.

Open the deed in the Belgian Official Gazette

2020
Annual accounts 2019 filed PDFabbreviated format · 18 days before the deadline
2019
Annual accounts 2018 filed PDFabbreviated format · 22 days before the deadline
2018
Annual accounts 2017 filed PDFabbreviated format · 33 days before the deadline
2017
Annual accounts 2016 filed PDFabbreviated format · 21 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 18 days before the deadline
2015
Annual accounts 2014 filed PDFabbreviated format · 4 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 21 days late
2013
Annual accounts 2012 filed PDFabbreviated format · 27 days late
2012
Annual accounts 2011 filed PDFabbreviated format · 14 days before the deadline
2011
Back to profit net €26,529 The net result is €26,529, after 3 loss-making years.
Annual accounts 2010 filed PDFabbreviated format · 26 days late
2010
Annual accounts 2009 filed PDFabbreviated format · 25 days before the deadline
2009
Liquidity more than 6 times current ratio 196.46 The current ratio rises from 30.50 to 196.46. Short-term debt falls from €7,126 to €1,053.
Annual accounts 2008 filed PDFfull format · 31 days before the deadline
2008
Weakest financial year net -€11,288 The net result drops to -€11,288, the lowest from 2006 to 2025. It recovers the following year.
Liquidity more than 12 times current ratio 30.50 The current ratio rises from 2.46 to 30.50. Short-term debt falls from €154,962 to €7,126.
Annual accounts 2007 filed PDFabbreviated format · 53 days late
2007
Equity above €200,000 equity €215,271 ▲8.5% With a profit in every financial year since 2006, equity grows to €215,271.
Annual accounts 2006 filed PDFabbreviated format · 2 days late
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
2003
Annual accounts 2002 filed PDFabbreviated format
2002
Annual accounts 2001 filed PDFabbreviated format
2001
Annual accounts 2000 filed PDFabbreviated format
2000
Annual accounts 1999 filed PDFabbreviated format
1999
Annual accounts 1998 filed PDFabbreviated format
1998
Annual accounts 1997 filed NBBabbreviated format
1997
Annual accounts 1996 filed NBBabbreviated format
1996
Annual accounts 1995 filed NBBabbreviated format
1995
Annual accounts 1994 filed NBBabbreviated format
1994
Annual accounts 1993 filed NBBabbreviated format
1993
Annual accounts 1992 filed NBBabbreviated format
1992
Annual accounts 1991 filed NBBabbreviated format
1991
Annual accounts 1990 filed NBBabbreviated format
1990
Annual accounts 1989 filed NBBabbreviated format
1989
Annual accounts 1988 filed NBBabbreviated format
1988
Annual accounts 1987 filed NBBabbreviated format
1987
Annual accounts 1986 filed NBBabbreviated format
1985
Incorporation published on 29-11-1985
First establishment Pharmacie Mediphar, Place de Cuesmes (C.) 7, Mons

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

MEDIFAR was incorporated on 6 November 1985.1 Total assets fell from €576,172 in 2018 to €490,803 in 2025 and headcount from 2.2 to 1 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Next steps